Biopharmaceutical companies at Hong Kong Science Park bring hope to cancer patients

  • Athenex develops oral alternative to intravenous chemotherapy and Bio-Cancer Treatment International’s drug slows leukaemia and melanoma tumour growth
  • Both companies strive to develop cancer treatments that produce fewer, less severe toxic side effects than conventional treatment of chemotherapy

Topic |   Healthy living: Tech for good
READ FULL ARTICLE